Related references
Note: Only part of the references are listed.Gaucher disease type 1 patients from the ICGG Gaucher Registry sustain initial clinical improvements during twenty years of imiglucerase treatment
Neal J. Weinreb et al.
MOLECULAR GENETICS AND METABOLISM (2021)
Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results
Pramod K. Mistry et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Mantle cell lymphoma polarizes tumor-associated macrophages into M2-like macrophages, which in turn promote tumorigenesis
Kang Le et al.
BLOOD ADVANCES (2021)
Tissue and Cell-Free DNA-Based Epigenomic Approaches for Cancer Detection
Alessandro Leal et al.
CLINICAL CHEMISTRY (2020)
Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease Registry
Yann Nguyen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Glucosylsphingosine but not Saposin C, is the target antigen in Gaucher disease-associated gammopathy
Shiny Nair et al.
MOLECULAR GENETICS AND METABOLISM (2020)
Are Glucosylceramide-Related Sphingolipids Involved in the Increased Risk for Cancer in Gaucher Disease Patients? Review and Hypotheses
Patricia Dubot et al.
CANCERS (2020)
Diffuse large B-cell non-Hodgkin's lymphoma in Gaucher disease
Grant Bonesteele et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2020)
Diagnosis and classification of lymphoma: Impact of technical advances
Elaine S. Jaffe
SEMINARS IN HEMATOLOGY (2019)
Epstein-Barr virus and its association with disease - a review of relevance to general practice
Anders Fugl et al.
BMC FAMILY PRACTICE (2019)
Endocrine and metabolic disorders in patients with Gaucher disease type 1: a review
Malgorzata Kaluzna et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Causes of death in 184 patients with type 1 Gaucher disease from the United States who were never treated with enzyme replacement therapy
Neal J. Weinreb et al.
BLOOD CELLS MOLECULES AND DISEASES (2018)
Hepatocellular carcinoma in Gaucher disease: an international case series
Martine Regenboog et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2018)
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance
Robert A. Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Molecular mechanisms of α-synuclein and GBA1 in Parkinson's disease
Iva Stojkovska et al.
CELL AND TISSUE RESEARCH (2018)
Antigen-mediated regulation in monoclonal gammopathies and myeloma
Shiny Nair et al.
JCI INSIGHT (2018)
Glucosylceramidases and malignancies in mammals
Leonardo Astudillo et al.
BIOCHIMIE (2016)
Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma
Shiny Nair et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy
Dai Chihara et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2015)
Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher disease-associated B-cell malignancy
Elena V. Pavlova et al.
JOURNAL OF PATHOLOGY (2015)
Malignant melanoma in early-treated Parkinson's disease: The NET-PD trial
Radu Constantinescu et al.
MOVEMENT DISORDERS (2014)
Inverse and Direct Cancer Comorbidity in People with Central Nervous System Disorders: A Meta-Analysis of Cancer Incidence in 577,013 Participants of 50 Observational Studies
Ferran Catala-Lopez et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2014)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
Erik von Elm et al.
INTERNATIONAL JOURNAL OF SURGERY (2014)
Strategies to reverse melanoma-induced T-cell dysfunction
Julien Fourcade et al.
CLINICS IN DERMATOLOGY (2013)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
B cell lymphoma and myeloma in murine Gaucher's disease
E. V. Pavlova et al.
JOURNAL OF PATHOLOGY (2013)
Extended remission of B-cell lymphoma with monoclonal gammopathy in a patient with type 1 Gaucher disease treated with enzyme replacement therapy
Fabrice Camou et al.
BLOOD CELLS MOLECULES AND DISEASES (2012)
Incidence of Monoclonal Gammopathy of Undetermined Significance and Estimation of Duration Before First Clinical Recognition
Terry M. Therneau et al.
MAYO CLINIC PROCEEDINGS (2012)
Insights into the Pathogenesis and Treatment of Cancer from Inborn Errors of Metabolism
Ayelet Erez et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
Vitamin D Receptor (VDR) polymorphic variants in patients with cancer and Gaucher disease
Michelle Lieblich et al.
BLOOD CELLS MOLECULES AND DISEASES (2011)
Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
Joseph R. Mazzulli et al.
CELL (2011)
Acquired immune-mediated thrombophilia in lymphoproliferative disorders
Klaus Lechner et al.
LEUKEMIA & LYMPHOMA (2011)
Meta-analysis of the relationship between Parkinson disease and melanoma
Rui Liu et al.
NEUROLOGY (2011)
Common pathogenic pathways in melanoma and Parkinson disease
Coro Paisan-Ruiz et al.
NEUROLOGY (2010)
The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients
Tamar H. Taddei et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
Ola Landgren et al.
BLOOD (2009)
Gaucher disease and monoclonal gammopathy: A report of 17 cases and impact of therapy
Bernard Grosbois et al.
BLOOD CELLS MOLECULES AND DISEASES (2009)
IgM monoclonal component associated with type I Gaucher disease resolved after enzyme replacement therapy: A case report
C. Martinez-Redondo et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2009)
Patients with Gaucher disease living in England show a high prevalence of vitamin D insufficiency with correlation to osteodensitometry
P. Mikosch et al.
MOLECULAR GENETICS AND METABOLISM (2009)
Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature
M. de Fost et al.
ANNALS OF HEMATOLOGY (2008)
Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance
Mirjam Langeveld et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
'Non-neuronopathic' Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature
M. Biegstraaten et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2008)
Risk of malignant disease among 1525 adult male US veterans with gaucher disease
Ola Landgren et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Increased incidence of cancer in adult Gaucher disease in Western Europe
M de Fost et al.
BLOOD CELLS MOLECULES AND DISEASES (2006)
Gaucher disease and cancer incidence: a study from the Gaucher Registry
BE Rosenbloom et al.
BLOOD (2005)
Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic
A Zimran et al.
BLOOD CELLS MOLECULES AND DISEASES (2005)
Effect of enzyme replacement therapy on gammopathies in Gaucher disease
A Brautbar et al.
BLOOD CELLS MOLECULES AND DISEASES (2004)
Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study
A Mele et al.
BLOOD (2003)
The development of aggressive cancer: A possible role for sphingolipids
NS Radin
CANCER INVESTIGATION (2002)
Decreased bone density in splenectomized Gaucher patients receiving enzyme replacement therapy
R Schiffmann et al.
BLOOD CELLS MOLECULES AND DISEASES (2002)
Share Paper
